Syncom Formulations (India) Limited — Others, 11-02-2025: Copy of Newspaper Publication

SYNCOM FORMULATIONS (INDIA) LIMITED has announced a board meeting to discuss the financial results for the quarter and nine months ending December 31, 2024. The consolidated total income from operations was ₹348.39 crore, with a net profit after tax of ₹27.18 crore. On a standalone basis, income from operations was ₹315.25 crore, leading to a profit after tax of ₹18.34 crore. This performance reflects a positive trend in operational efficiency and profitability. Investors may view this as a positive outlook, suggesting improvements in financial health and earnings potential moving forward. Detailed financial results are accessible on the company's website.